Retatrutide UK: Availability, Safety and Alternatives

Retatrutide is generating serious buzz as the next breakthrough in weight loss treatment, and if you live in the UK, you probably have questions. Can you buy retatrutide in the UK right now? Is it safe? And how does it compare to treatments like Mounjaro and Wegovy that are already available?

This guide covers everything you need to know about retatrutide in the UK: what it is, how it works, clinical trial results, regulatory status, side effects and what your safe, effective options are right now.

What Is Retatrutide?

Retatrutide (also known by its development code LY3437943) is an injectable weight loss medication developed by Eli Lilly. It belongs to a new class of drugs called triple agonists because it targets three hormone receptors at once:

• GLP-1 (glucagon-like peptide-1) — reduces appetite and slows stomach emptying
• GIP (glucose-dependent insulinotropic polypeptide) — improves insulin sensitivity and enhances fat metabolism
• Glucagon — increases energy expenditure and promotes fat burning

This triple-action approach sets retatrutide apart from existing treatments. Mounjaro (tirzepatide) targets two of these receptors (GLP-1 and GIP), while Wegovy (semaglutide) targets just one (GLP-1). The addition of the glucagon receptor is what makes researchers particularly excited about retatrutide's potential.

Retatrutide Clinical Trial Results

The headline results from retatrutide's Phase 2 clinical trial (published in The New England Journal of Medicine in 2023) were remarkable:

• Participants on the highest dose (12 mg) lost an average of 24.2% of their body weight over 48 weeks
• At 48 weeks, 100% of participants on the 12 mg dose had lost at least 5% of their body weight
• Over 90% had lost at least 10%
• Significant improvements in blood sugar levels, blood pressure and cholesterol were also observed

To put that in perspective, Mounjaro's trials showed average weight loss of around 15–21% and Wegovy's trials showed around 15%. Retatrutide's 24% average is a meaningful step forward.

Phase 3 trials (larger, longer studies needed for regulatory approval) are currently underway, with results expected in the coming years.

Is Retatrutide Available in the UK?

The short answer: no, retatrutide is not yet available in the UK through any legitimate, regulated channel.

Here is why:

• Retatrutide has not been approved by the MHRA (Medicines and Healthcare products Regulatory Agency), the UK body responsible for authorising new medicines
• It has not completed Phase 3 clinical trials, which are required before any drug can be submitted for regulatory approval
• There is no licensed retatrutide product available from any UK pharmacy, clinic or healthcare provider
• Eli Lilly has not yet announced a brand name or pricing for the UK market

The typical timeline from Phase 3 trial completion to UK availability is 2–4 years, factoring in regulatory review, NICE appraisal (for NHS coverage) and commercial launch. Realistically, retatrutide is unlikely to be available in the UK before 2027 at the earliest.

Can You Buy Retatrutide Online in the UK?

You may have seen websites claiming to sell retatrutide in the UK. These products are not legitimate pharmaceutical-grade retatrutide and buying them carries serious risks:

Safety concerns:

• Products sold online are typically "research-grade" peptides intended for laboratory use, not human consumption
• There is no guarantee of purity, dosage accuracy or sterility
• These products have not been tested for safety in humans
• Contamination with harmful substances is a real risk
• The MHRA has actively seized illegal weight loss products, including peptides sold online

Legal concerns:

• Selling an unlicensed medicine for human use in the UK is illegal
• While purchasing for personal use occupies a grey area, the products themselves are unregulated
• No legitimate UK pharmacy or prescriber can supply retatrutide

Health risks:

• Without medical supervision, there is no safe way to determine the correct retatrutide dosage
• Drug interactions and contraindications cannot be properly assessed
• Side effects cannot be monitored or managed by a healthcare professional
• If something goes wrong, emergency services may not know what you have taken

The bottom line: buying retatrutide online in the UK is unsafe, unregulated and potentially illegal. No reputable healthcare provider would recommend it.

Retatrutide Side Effects

Based on clinical trial data, the most common retatrutide side effects include:

Gastrointestinal side effects (the most frequently reported):

• Nausea
• Diarrhoea
• Vomiting
• Constipation
• Decreased appetite

These are similar to the side effects seen with other GLP-1 based medications like Mounjaro and Wegovy. In clinical trials, gastrointestinal side effects were generally mild to moderate and tended to improve over time, particularly with gradual dose escalation.

Other reported side effects:

• Increased heart rate
• Injection site reactions
• Dizziness
• Fatigue

Because retatrutide also acts on the glucagon receptor, researchers are closely monitoring its effects on heart rate and liver fat. Early data is encouraging, showing significant reductions in liver fat, but longer-term safety data from Phase 3 trials will be essential.

Retatrutide Dosage: What the Trials Tell Us

In the Phase 2 trial, retatrutide was tested at several dosage levels, administered as a weekly subcutaneous injection (similar to Mounjaro and Wegovy):

• Starting doses: 1 mg, 4 mg or 8 mg weekly, with gradual escalation
• Maintenance doses tested: 4 mg, 8 mg and 12 mg weekly
• Best results: The 12 mg dose showed the greatest weight loss (24.2% average)
• Dose escalation: All groups followed a titration schedule, starting lower and increasing gradually to reduce side effects

The exact dosing regimen for the commercial product will be determined by Phase 3 trial results and regulatory approval. It is likely to follow a similar pattern to Mounjaro — starting at a lower dose and increasing over several months.

Retatrutide Price: What Might It Cost in the UK?

No official UK pricing has been announced for retatrutide. However, we can make some educated guesses based on comparable treatments:

Retatrutide may command a premium over existing treatments given its triple-agonist mechanism and potentially superior weight loss results. NHS availability would depend on a NICE technology appraisal, which considers both clinical effectiveness and cost-effectiveness.

How Does Retatrutide Compare to Mounjaro and Wegovy?

While retatrutide's trial results are impressive, it is important to remember that Phase 2 trials involve smaller groups of participants than Phase 3. Real-world results may differ, and head-to-head comparisons with Mounjaro and Wegovy have not yet been conducted.

What Are Your Options Right Now?

If you are interested in clinically proven, MHRA-approved weight loss treatments available in the UK today, two strong options exist:

Mounjaro (tirzepatide) is the closest relative to retatrutide, targeting two of the same three receptors. Clinical trials showed average weight loss of up to 21%, and it is widely regarded as the most effective weight loss medication currently available in the UK. Learn more about how Mounjaro works.

Wegovy (semaglutide) targets the GLP-1 receptor and has shown average weight loss of around 15% in clinical trials. It has a well-established safety profile and is available through various UK providers. Read about managing GLP-1 side effects.

Both medications should be prescribed by a qualified healthcare professional as part of a comprehensive weight management programme that includes dietary guidance, physical activity support and ongoing medical monitoring. See how to choose the right provider.

Frequently Asked Questions

When will retatrutide be available in the UK?

Retatrutide is unlikely to be available in the UK before 2027 at the earliest. Phase 3 clinical trials must be completed, followed by MHRA regulatory review and commercial launch. The exact timeline depends on trial results and the speed of the approval process.

Is retatrutide better than Mounjaro?

Phase 2 trial data suggests retatrutide may produce greater average weight loss than Mounjaro (24% vs 15–21%), likely due to its additional glucagon receptor activity. However, head-to-head trials have not been conducted, and Phase 3 results are still pending. Mounjaro remains the most effective MHRA-approved option available now.

Can I get retatrutide on the NHS?

Not currently. Retatrutide is not yet approved for use in the UK. If and when it receives MHRA approval, NHS availability would depend on a NICE technology appraisal — a process that typically takes an additional 12–18 months after regulatory approval.

What is the difference between retatrutide and semaglutide?

Semaglutide (the active ingredient in Wegovy and Ozempic) targets the GLP-1 receptor only. Retatrutide targets three receptors: GLP-1, GIP and glucagon. This triple-action mechanism appears to produce greater weight loss in clinical trials, though long-term comparative data is not yet available.

Is it safe to buy retatrutide peptides online?

No. Retatrutide peptides sold online in the UK are unregulated, unlicensed research chemicals not intended for human use. They carry significant risks including contamination, incorrect dosing and lack of medical supervision. The MHRA has warned against purchasing unlicensed weight loss medicines online.

The Bottom Line

Retatrutide represents an exciting advance in weight loss medicine, and its clinical trial results are impressive. But it is not yet available through any safe, legal or regulated route in the UK and it will not be for some time.

If you are looking for effective, doctor-supervised weight loss treatment today, MHRA-approved options like Mounjaro and Wegovy offer proven results with established safety profiles. Speaking with a qualified healthcare professional is the best first step.

This article was medically reviewed for accuracy. It is intended for informational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting any weight loss treatment.